These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 21969587)

  • 1. Full activity of the deleted in liver cancer 1 (DLC1) tumor suppressor depends on an LD-like motif that binds talin and focal adhesion kinase (FAK).
    Li G; Du X; Vass WC; Papageorge AG; Lowy DR; Qian X
    Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17129-34. PubMed ID: 21969587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LD Motif Recognition by Talin: Structure of the Talin-DLC1 Complex.
    Zacharchenko T; Qian X; Goult BT; Jethwa D; Almeida TB; Ballestrem C; Critchley DR; Lowy DR; Barsukov IL
    Structure; 2016 Jul; 24(7):1130-41. PubMed ID: 27265849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDK5 is a major regulator of the tumor suppressor DLC1.
    Tripathi BK; Qian X; Mertins P; Wang D; Papageorge AG; Carr SA; Lowy DR
    J Cell Biol; 2014 Dec; 207(5):627-42. PubMed ID: 25452387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solution structure of the phosphotyrosine binding (PTB) domain of human tensin2 protein in complex with deleted in liver cancer 1 (DLC1) peptide reveals a novel peptide binding mode.
    Chen L; Liu C; Ko FC; Xu N; Ng IO; Yam JW; Zhu G
    J Biol Chem; 2012 Jul; 287(31):26104-14. PubMed ID: 22645138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor activates the Rho GTPase-activating protein (GAP) Deleted in Liver Cancer 1 via focal adhesion kinase and protein phosphatase 2A.
    Ravi A; Kaushik S; Ravichandran A; Pan CQ; Low BC
    J Biol Chem; 2015 Feb; 290(7):4149-62. PubMed ID: 25525271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deleted in liver cancer 1 (DLC1) utilizes a novel binding site for Tensin2 PTB domain interaction and is required for tumor-suppressive function.
    Chan LK; Ko FC; Ng IO; Yam JW
    PLoS One; 2009; 4(5):e5572. PubMed ID: 19440389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities.
    Qian X; Li G; Asmussen HK; Asnaghi L; Vass WC; Braverman R; Yamada KM; Popescu NC; Papageorge AG; Lowy DR
    Proc Natl Acad Sci U S A; 2007 May; 104(21):9012-7. PubMed ID: 17517630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of the activity of deleted in liver cancer 1 (DLC1) by tensins controls cell migration and transformation.
    Cao X; Voss C; Zhao B; Kaneko T; Li SS
    Proc Natl Acad Sci U S A; 2012 Jan; 109(5):1455-60. PubMed ID: 22307599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concerted modulation of paxillin dynamics at focal adhesions by Deleted in Liver Cancer-1 and focal adhesion kinase during early cell spreading.
    Kaushik S; Ravi A; Hameed FM; Low BC
    Cytoskeleton (Hoboken); 2014 Dec; 71(12):677-94. PubMed ID: 25448629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression.
    Yam JW; Ko FC; Chan CY; Jin DY; Ng IO
    Cancer Res; 2006 Sep; 66(17):8367-72. PubMed ID: 16951145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. START-GAP1/DLC1 is localized in focal adhesions through interaction with the PTB domain of tensin2.
    Kawai K; Kitamura SY; Maehira K; Seike J; Yagisawa H
    Adv Enzyme Regul; 2010; 50(1):202-15. PubMed ID: 19895840
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of small interfering RNA transfection on FAK and DLC1 mRNA expression in OVCAR-3.
    Shi H; Liu H; Zhao G
    Mol Biol Rep; 2012 Oct; 39(10):9299-306. PubMed ID: 22760257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-Associated Point Mutations in the
    Wang D; Qian X; Sanchez-Solana B; Tripathi BK; Durkin ME; Lowy DR
    Cancer Res; 2020 Sep; 80(17):3568-3579. PubMed ID: 32606003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SRC and ERK cooperatively phosphorylate DLC1 and attenuate its Rho-GAP and tumor suppressor functions.
    Tripathi BK; Anderman MF; Qian X; Zhou M; Wang D; Papageorge AG; Lowy DR
    J Cell Biol; 2019 Sep; 218(9):3060-3076. PubMed ID: 31308216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanotransduction in talin through the interaction of the R8 domain with DLC1.
    Haining AWM; Rahikainen R; Cortes E; Lachowski D; Rice A; von Essen M; Hytönen VP; Del Río Hernández A
    PLoS Biol; 2018 Jul; 16(7):e2005599. PubMed ID: 30028837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppressor gene DLC1: Its modifications, interactive molecules, and potential prospects for clinical cancer application.
    Ren G; Li G
    Int J Biol Macromol; 2021 Jul; 182():264-275. PubMed ID: 33836193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tensin1 positively regulates RhoA activity through its interaction with DLC1.
    Shih YP; Sun P; Wang A; Lo SH
    Biochim Biophys Acta; 2015 Dec; 1853(12):3258-65. PubMed ID: 26427649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p120Ras-GAP binds the DLC1 Rho-GAP tumor suppressor protein and inhibits its RhoA GTPase and growth-suppressing activities.
    Yang XY; Guan M; Vigil D; Der CJ; Lowy DR; Popescu NC
    Oncogene; 2009 Mar; 28(11):1401-9. PubMed ID: 19151751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of deleted in liver cancer 1 and phosphorelated focal adhesion kinase in breast cancer].
    Feng Y; Zhou HX; Li JH; Li ZY; Cheng WG; Jin ML; He L
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Aug; 31(8):1448-51. PubMed ID: 21868344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of DLC1 upregulates PAI-1 expression and reduces migration in normal prostate cells.
    Shih YP; Takada Y; Lo SH
    Mol Cancer Res; 2012 Jan; 10(1):34-9. PubMed ID: 22064653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.